G Ferrari, AJ Thrasher, A Aiuti - Nature Reviews Genetics, 2021 - nature.com
Haematopoietic stem and progenitor cell (HSPC) gene therapy has emerged as an effective treatment modality for monogenic disorders of the blood system such as primary …
Therapeutic applications of nuclease-based genome editing would benefit from improved methods for transgene integration via homology-directed repair (HDR). To improve HDR …
S Ferrari, A Jacob, D Cesana, M Laugel, S Beretta… - Cell Stem Cell, 2022 - cell.com
Long-range gene editing by homology-directed repair (HDR) in hematopoietic stem/progenitor cells (HSPCs) often relies on viral transduction with recombinant adeno …
Cas9 is commonly introduced into cell lines to enable CRISPR–Cas9-mediated genome editing. Here, we studied the genetic and transcriptional consequences of Cas9 expression …
Precise gene editing in hematopoietic stem and progenitor cells (HSPCs) holds promise for treating genetic diseases. However, responses triggered by programmable nucleases in …
The growing clinical success of hematopoietic stem/progenitor cell (HSPC) gene therapy (GT) relies on the development of viral vectors as portable" Trojan horses" for safe and …
MM Álvarez, J Biayna, F Supek - Nature communications, 2022 - nature.com
CRISPR/Cas9 gene editing can inactivate genes in a precise manner. This process involves DNA double-strand breaks (DSB), which may incur a loss of cell fitness. We hypothesize that …
AMS Giordano, M Luciani, F Gatto… - Journal of Experimental …, 2022 - rupress.org
Aberrant induction of type I IFN is a hallmark of the inherited encephalopathy Aicardi- Goutières syndrome (AGS), but the mechanisms triggering disease in the human central …
M Cavazzana, FD Bushman, A Miccio… - Nature reviews Drug …, 2019 - nature.com
Pioneering gene therapy trials have shown that the genetic engineering of haematopoietic stem and progenitor cells can be an alternative to allogeneic transplantation in the treatment …